Drug details

Bioclate (antihemophilic factor)

type of Hemostatics, Coagulation Factors

Bioclate (antihemophilic factor [recombinant]) is a glyco-protein used in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes. Bioclate is also indicated in the perioperative management of patients with hemophilia A. Bioclate may be available in generic form.

This drug may have the following side effects:

• nausea
• fever
• vomiting
• chills
• fatigue
• abdominal pain
• upset stomach
• nosebleeds
• flushing, and
• injection site reactions (burning, redness, or irritation).
  

The following drugs are related to Bioclate, either as a replacement or used together:

• Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
• Afstyla (antihemophilic factor recombinant intravenous injection)
• Alprolix ([coagulation factor ix (recombinant), fc fusion protein], lyophilized powder for solution for intravenous injection)
• Kovaltry (antihemophilic factor (recombinant) for intravenous administration)
• Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
• Bebulin VH (factor ix complex intravenous administration)